This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday – Cytokinetics (NASDAQ:CYTK), ACCESS Newswire (AMEX:ACCS)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Barclays analyst Gena Wang initiated coverage on Cytokinetics, Incorporated CYTK with an Overweight rating and announced a price target of $5. Cytokinetics shares closed at $38.00 on Wednesday. See how other analysts view this stock.
• Lake Street analyst Jacob Stephan initiated coverage on ACCESS Newswire Inc. ACCS with a Buy rating and announced a price target of $15. ACCESS Newswire shares closed at $8.65 on Wednesday. See how other analysts view this stock.

Considering buying CYTK stock? Here’s what analysts think:

Read This Next:

• Top 2 Consumer Stocks That May Implode This Month

Photo via Shutterstock